美股周一早盘,以色列临床医疗诊断公司Check-Cap公司(CHEK)股价飙升233.8%,此前其与MBody AI达成合并协议。根据协议,MBody AI将持有合并后实体90%的股份,Check-Cap保留10%的股份,双方旨在进军高增长的人工智能行业。
责任编辑:张俊 SF065
美股周一早盘,以色列临床医疗诊断公司Check-Cap公司(CHEK)股价飙升233.8%,此前其与MBody AI达成合并协议。根据协议,MBody AI将持有合并后实体90%的股份,Check-Cap保留10%的股份,双方旨在进军高增长的人工智能行业。
责任编辑:张俊 SF065
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.